ArticleFrontiers in pharmacology2021

The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma.

Hongmei Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.